Showing results (51-60 of 182) with videos related to
Sort By:
Pageof 19
European Urology Open Science|August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center ExperienceMarco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.Optics Letters|April 15, 2024
Liquid crystal wave plate operating close to 18 THzFabio Novelli, Patrick Friebel, Marta L Murillo-Sanchez, et al.The Review of Scientific Instruments|October 7, 2024
Liquid crystal-based temperature-controlled recirculating flat jet systemMarta L Murillo-Sánchez, Natalia Copete-Plazas, Elias Bürkle, et al.Journal of Neuro-Oncology|October 13, 2006
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiformeGiuseppe Luigi Banna, Daniela Bettio, Marta Scorsetti, et al.Cancers|March 28, 2025
Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study)Maria Susanna Grimaudo, Federico D'Orazio, Salvatore Lorenzo Renne, et al.Journal of Veterinary Science|September 15, 2004
Echocardiography and electrocardiography as means to evaluate potential performance in horsesCarlos Lightowler, Giuseppe Piccione, Elisabetta Giudice, et al.Korean Journal of Urology|June 17, 2015
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancerGianluigi Taverna, Fabio Grizzi, Piergiuseppe Colombo, et al.Cancer Research|November 4, 2015
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1Roberta Mazzieri, Giovanni Pietrogrande, Laura Gerasi, et al.Frontiers in Medicine|November 25, 2024
Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumorsPiergiuseppe Colombo, Giuseppina Adriana Buonamassa, Anita Giulianini, et al.Frontiers in Oncology|June 6, 2022
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective TrialRoberto Contieri, Giovanni Lughezzani, Nicolò Maria Buffi, et al.Pageof 19